Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- F-4 Registration of securities (foreign)
- 3.2 Exhibit 3.2
- 4.5 Exhibit 4.5
- 4.6 Exhibit 4.6
- 5.1 Exhibit 5.1
- 5.2 Exhibit 5.2
- 10.5 Exhibit 10.5
- 10.6 Exhibit 10.6
- 10.9 Exhibit 10.9
- 10.10 Exhibit 10.10
- 10.11 Exhibit 10.11
- 10.12 Exhibit 10.12
- 10.13 Exhibit 10.13
- 21.1 Exhibit 21.1
- 23.1 Exhibit 23.1
- 23.2 Exhibit 23.2
- 23.3 Exhibit 23.3
- 23.7 Exhibit 23.7
- 99.2 Exhibit 99.2
- 99.3 Exhibit 99.3
- 99.4 Exhibit 99.4
- 99.5 Exhibit 99.5
- EX-FILING FEES Ex-filing Fees
Associated filings
- 21 Feb 23 424B3 Prospectus supplement
- 8 Feb 23 424B3 Prospectus supplement
- 8 Feb 23 EFFECT Notice of effectiveness
- 3 Feb 23 F-4/A Registration of securities (foreign) (amended)
- 25 Jan 23 F-4/A Registration of securities (foreign) (amended)
- 13 Jan 23 F-4/A Registration of securities (foreign) (amended)
-
28 Dec 22 F-4 Registration of securities (foreign)
LSB similar filings
Filing view
External links
Exhibit 4.5
YS Biopharma Co., Ltd
Number | Ordinary Shares |
[ ] | -[no. of shares]- |
Incorporated under the laws of the Cayman Islands
Share capital is US$50,000 divided into 2,500,000,000 Ordinary Shares with a par value of US$0.00002 each
THIS IS TO CERTIFY THAT [name of shareholder] is the registered holder of [no. of shares] Ordinary Shares in the above-named Company subject to the Memorandum and Articles of Association thereof.
GIVEN UNDER the common seal of the said Company on 20
THE COMMON SEAL of the said Company was hereunto affixed in the presence of:
DIRECTOR |